SCHEMBL644998

SCHEMBL644998

O=P(O)(O)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28446508 0.78
Phosphoric Acid SCHEMBL2639135 0.76 KDM4E (0.43)
Phosphoric Acid SCHEMBL2722872 0.76
Phosphoric Acid SCHEMBL5797703 0.76 KDM4E (0.43)
Phosphoric Acid SCHEMBL1334770 0.76 KDM4E (0.43)
Phosphoric Acid SCHEMBL6538439 0.73 KDM4E (0.40)
Phosphoric Acid SCHEMBL3436971 0.73 KDM4E (0.40)
Phosphoric Acid SCHEMBL28998696 0.73 KDM4E (0.40)
SCHEMBL4124789 0.73
SCHEMBL2511647 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013037707-A1 POLYMERIZATION PROCESS SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2013-03-21 WO claimed
EP-1140980-B1 PSEUDOPEPTIDE COMPOUNDS HAVING AN INHIBITING ACTIVITY WITH RESPECT TO PATHS ACTIVATED BY PROTEINS WITH ACTIVE TYROSINE KINASE ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME INST NAT SANTE RECH MED (FR) 2004-09-29 EP claimed
US-20020055463-A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2002-05-09 US claimed
EP-0335770-B1 Novel fluorophosphonate nucleotide derivatives MERRELL PHARMA INC (US) 1997-01-15 EP claimed
WO-2026107062-A1 STAT6 DEGRADERS AND USES THEREOF RECLUDIX PHARMA, INC. (US) 2026-05-21 WO disclosed
US-20260015373-A1 STAT6 MODULATORS AND USES THEREOF RECLUDIX PHARMA INC (US) 2026-01-15 US disclosed
US-20250215029-A1 STAT MODULATORS AND USES THEREOF RECLUDIX PHARMA, INC. 2025-07-03 US disclosed
EP-3215577-B1 ADDITIVES FOR IMPROVED HIDING AND PAINT COMPOSITIONS CONTAINING SAME MOORE BENJAMIN & CO (US) 2020-07-01 EP disclosed
CN-106165175-B High molecular electrolyte composition and polyelectrolyte membrane, film electrode composite element and the polymer electrolyte fuel cell for using it 东丽株式会社 2019-11-08 CN disclosed
CN-106165175-A High molecular electrolyte composition and use its polyelectrolyte membrane, film electrode composite element and polymer electrolyte fuel cell 东丽株式会社 2016-11-23 CN disclosed
CN-105770878-A Vaccine Nanotechnology 麻省理工学院 2016-07-20 CN disclosed
CN-104395743-A Amperometric gas sensor STERIS CORP 2015-03-04 CN disclosed
EP-0335770-A3 NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES MERRELL PHARMACEUTICALS INC. (US) 1990-12-27 EP disclosed
EP-0339161-A1 Novel fluorophosphonate nucleotide derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-11-02 EP disclosed
EP-0339161-A1 Novel fluorophosphonate nucleotide derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-11-02 EP disclosed
CN-1036578-A NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES MERRELL DOW PHARMA (US) 1989-10-25 CN disclosed
EP-0335770-A2 Novel fluorophosphonate nucleotide derivatives MERRELL PHARMACEUTICALS INC. (US) 1989-10-04 EP disclosed
EP-0335770-A2 Novel fluorophosphonate nucleotide derivatives MERRELL PHARMACEUTICALS INC. (US) 1989-10-04 EP disclosed
CN-88100675-A ANTIOXIDANT AROMATIC FLUOROPHOSPHITES 1988-11-09 CN disclosed
US-4309310-A TO UNSATURATED ACIDS OR ALDEHYDES; VANADIUM OR MOLYBDENUM OXIDE COMPLEX OF PERFLUORO ALKYL SULFONATE OR PHOSPHONATE STANDARD OIL COMPANY (US) 1982-01-05 US disclosed